Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 1/2008

01-03-2008 | Original Article

Surgical treatment of recurrent gastric cancer

Authors: Álvaro Díaz De Liaño, Concepción Yarnoz, Rubén Aguilar, Cristina Artieda, Héctor Ortiz

Published in: Gastric Cancer | Issue 1/2008

Login to get access
Metadata
Title
Surgical treatment of recurrent gastric cancer
Authors
Álvaro Díaz De Liaño
Concepción Yarnoz
Rubén Aguilar
Cristina Artieda
Héctor Ortiz
Publication date
01-03-2008
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 1/2008
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-007-0444-5

Other articles of this Issue 1/2008

Gastric Cancer 1/2008 Go to the issue

Original Article

Chromoendoscopy with hematoxylin in the classificaton of gastric lesions

Letter to the Editor

Locoregional control remains a critical issue in gastric cancer

Case Report

Suture-line recurrence at a jejunojejunal anastomosis after gastrectomy for gastric cancer

Original Article

Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III human gastric carcinoma: clinicopathological significance

Original Article

Citrus fruit intake and stomach cancer risk: a quantitative systematic review

Review Article

The new credo: induction chemotherapy in locally advanced gastric cancer: consequences for surgical strategies
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits